Global Lithium Drug Market, By Disorders (Bipolar Disorder, Depression, Schizophrenia, Mania, Attention-Deficit Hyperactivity Disorder, Others), Drug Type (Generic, Branded), Dosage (Tablets, Capsules, Solutions, Others), End-Users (Hospitals, Specialty Clinics, Home Healthcare, Others), Distribution Channel (Direct Tender, Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil in North America, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) - Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Lithium Drug Market
Global lithium drug market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR 4.30% in the above-mentioned research forecast period. Rising neurological diseases/disorders such as bipolar disorder, mania, depression and other mental disorder are the factors responsible for the growth of this market.
However, growing elder and geriatric population diagnosed with depression and other mood disorders also boost up the market growth. Moreover, rising cases of depression in females in developing countries also boost up the market growth. But, strict dose monitoring, presence of alternative medication & organic products and adverse drug reaction related to the lithium usage may hamper the global lithium drug market.
Lithium drug is one of the widely used and researched drug for the treatment of bipolar disorders and mania. The exact working of the lithium not known but it can stated that it acts on a person's central nervous system (such as spinal cord and brain). It increases the activity of certain chemical messengers in the brain which leads to stabilization of patient mood. It is also assumed that lithium helps to strengthen nerve cell connections in brain regions which regulate the mood or behaviour pf the patient. It take several weeks for lithium to begin working and required routine blood test because it affects thyroid and kidney function.
According to the national institute of mental health it is estimated that approximately 2.8% adults has bipolar disorder in the U.S. and it is estimated that 4.4% of the U.S. adult population may face bipolar disorder at some point in their lives.
This lithium drug market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Lithium Drug Market Scope and Market Size
The lithium drug market is segmented on the basis of disorders, drug type, dosage, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of disorders, the lithium drug market is segmented into bipolar disorder, depression, schizophrenia, mania, attention-deficit hyperactivity disorder and others. Bipolar disorder further segmented into type 1 and type 2.
- On the basis of drug type, the lithium drug market is segmented into branded and generics. Branded drugs further segmented into Eskalith, Lithobid and others.
- On the basis of dosage, the lithium drug market is segmented into tablet, capsule, solution and others.
- On the basis of end-users, the lithium drug market is segmented into hospitals, specialty clinics and others.
- On the basis of distribution channel, the lithium drug market has also been segmented into direct tender, hospital pharmacy, retail pharmacy, online pharmacy and others.
Lithium Drug Market Country Level Analysis
Lithium drug market is analysed and market size information is provided by country, disorders, drug type, dosage, end-users and distribution channel as referenced above.
The countries covered in the lithium drug market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
On geographical estimation, North America accounts the largest market share due to the presence of rising population with bipolar and depressive disorders, high healthcare expenditure and research & development. Europe accounts the second largest market share due to presence of refined medical facilities. Asia-Pacific is expected to account for the largest market share over coming years for the Lithium Drug market due to increased advancement in the technology as well as growing healthcare expenditure and rising awareness program.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Lithium drug market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Lithium Drug Market Share Analysis
Lithium drug market competitive landscape provides details by competitor details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to lithium drug market.
The major players covered in the lithium drug market are Talison Lithium Limited, Nemaska Lithium Inc., Sociedad Quimica y Minera, Orocobre Limited, Quinghai Lithium, Citic Guoan MGL, SQM Ltd., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-